Ambulatory Aids are devices used to enhance the motion of the body. It acts as an assistive device. Ambulatory aids are used to provide an extension in the upper body parts and provide external support to the patient. These devices are primarily used to improve the motion of the disabled body. Various devices related to ambulatory aids are wheelchairs, scooters, rollators etc. These devices are used by the hospitals and individuals for the easy motion of the body. The companies operating in the ambulatory aids market are continuously launching fully automatic ambulatory aids. These devices help the disabled person to perform daily activities. These devices are light weight which increases the convenience of the patients.
Market Size and Forecast
The global ambulatory aids market is expected to grow at a substantial CAGR during 2018-2027. It is projected to attain significant market value by 2027. The growing geriatric population and rising incidences of the chronic diseases such as arthritis and Parkinson’s disease is anticipated to increase the market growth of the global ambulatory aids market during the forecast period. The global ambulatory aids market can be segmented on the basis of product type and region. On the basis of product type it is segmented into wheelchairs, scooters, mobility aids, rollators and others. The wheelchairs are of two type manual and power. The rollators is anticipated to be the largest sub-segment on the account of its ability to carry heavy weight patients effectively. The enhanced adjustment mechanism of the premium rollators are expected to increase the penetration of the premium rollators in the market. The premium rollators are built with soft seat which makes the better seating experience for the elderly people. The other sub-segment includes canes, crutches, and walkers. The others sub-segment is anticipated to observe considerable market growth throughout the forecast period.
By region, global ambulatory aids market is segmented into North America, Asia-Pacific, Latin America, Europe, Middle East and Africa. North America is anticipated to be the largest region for the global ambulatory aids market. The presence of developed healthcare setup in the region is anticipated to be the major factor for the expansion of the global ambulatory aids market. The increasing rate of chronic disease in the region is also a reason for the increasing demand for the ambulatory devices in the region. According to centers of disease control and prevention (CDC), it is estimated that 54.4 million people are suffering from arthritis in U.S. Asia-Pacific is anticipated to be the fastest developing region for the global ambulatory aids market. The increasing geriatric population coupled with key government initiatives is anticipated to boost the growth of the global ambulatory aids market.
Our in-depth analysis segmented the global ambulatory aids market in the following segments:
Global ambulatory aids market is further classified on the basis of region as follows:
Growth Drivers and Challenges
The rising prevalence of the chronic disease among the geriatric population is anticipated to be a major growth driver for the global ambulatory aids market throughout the forecast period. The increasing funds by the government in order to support the physically disabled people are anticipated to boost the demand for the ambulatory aids devices. Additionally, the government is assisting the physically disabled population by providing funds. The increasing technological development in order to develop automatic machines is anticipated to fuel the market growth of the ambulatory aids market globally.
However, high cost associated with various ambulatory devices is anticipated to be a major restraint for the global ambulatory aids market during the forecast period.
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization
Great focus on accuracy and quality of the research
(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495